EMA Authorised: Ixchiq (Chikungunya virus, strain CHIKV LR2006-OPY1, live attenuated) — Valneva Austria GmbH

View source ↗

Summary

The EMA has authorised Ixchiq, a live attenuated chikungunya virus vaccine (strain CHIKV LR2006-OPY1) by Valneva Austria GmbH, for therapeutic use against chiku…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chikungunya Fever
• Chikungunya Virus Infection

Drugs mentioned

• Ixchiq

Snippet

Status: Authorised. Therapeutic area: Chikungunya virus. MAH: Valneva Austria GmbH. Decision date: 05/06/2026